These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28784610)

  • 1. Impaired JIP3-dependent axonal lysosome transport promotes amyloid plaque pathology.
    Gowrishankar S; Wu Y; Ferguson SM
    J Cell Biol; 2017 Oct; 216(10):3291-3305. PubMed ID: 28784610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques.
    Gowrishankar S; Yuan P; Wu Y; Schrag M; Paradise S; Grutzendler J; De Camilli P; Ferguson SM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):E3699-708. PubMed ID: 26124111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.
    Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX
    Eur J Neurosci; 2009 Dec; 30(12):2271-83. PubMed ID: 20092570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice.
    Cuddy LK; Alia AO; Salvo MA; Chandra S; Grammatopoulos TN; Justman CJ; Lansbury PT; Mazzulli JR; Vassar R
    Mol Neurodegener; 2022 Aug; 17(1):54. PubMed ID: 35987691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping roles of JIP3 and JIP4 in promoting axonal transport of lysosomes in human iPSC-derived neurons.
    Gowrishankar S; Lyons L; Rafiq NM; Roczniak-Ferguson A; De Camilli P; Ferguson SM
    Mol Biol Cell; 2021 May; 32(11):1094-1103. PubMed ID: 33788575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JIP3 links lysosome transport to regulation of multiple components of the axonal cytoskeleton.
    Rafiq NM; Lyons LL; Gowrishankar S; De Camilli P; Ferguson SM
    Commun Biol; 2022 Jan; 5(1):5. PubMed ID: 35013510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease.
    Peters F; Salihoglu H; Pratsch K; Herzog E; Pigoni M; Sgobio C; Lichtenthaler SF; Neumann U; Herms J
    EMBO J; 2019 Dec; 38(23):e102345. PubMed ID: 31701556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK-interacting protein 3 mediates the retrograde transport of activated c-Jun N-terminal kinase and lysosomes.
    Drerup CM; Nechiporuk AV
    PLoS Genet; 2013; 9(2):e1003303. PubMed ID: 23468645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIN1 regulates BACE1 intracellular trafficking and amyloid-β production.
    Miyagawa T; Ebinuma I; Morohashi Y; Hori Y; Young Chang M; Hattori H; Maehara T; Yokoshima S; Fukuyama T; Tsuji S; Iwatsubo T; Prendergast GC; Tomita T
    Hum Mol Genet; 2016 Jul; 25(14):2948-2958. PubMed ID: 27179792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-mediated Regulation of BACE1 Protein Trafficking and Degradation.
    Feng T; Tammineni P; Agrawal C; Jeong YY; Cai Q
    J Biol Chem; 2017 Feb; 292(5):1679-1690. PubMed ID: 28028177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.
    Cai Y; Xiong K; Zhang XM; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Chu Y; Kordower JH; Yan XX
    Eur J Neurosci; 2010 Oct; 32(7):1223-38. PubMed ID: 20726888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease.
    Kizuka Y; Kitazume S; Fujinawa R; Saito T; Iwata N; Saido TC; Nakano M; Yamaguchi Y; Hashimoto Y; Staufenbiel M; Hatsuta H; Murayama S; Manya H; Endo T; Taniguchi N
    EMBO Mol Med; 2015 Feb; 7(2):175-89. PubMed ID: 25592972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional deprivation promotes amyloid plaque pathogenesis in Tg2576 mouse olfactory bulb and piriform cortex.
    Zhang XM; Xiong K; Cai Y; Cai H; Luo XG; Feng JC; Clough RW; Patrylo PR; Struble RG; Yan XX
    Eur J Neurosci; 2010 Feb; 31(4):710-21. PubMed ID: 20384814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
    Cui H; King AE; Jacobson GA; Small DH
    J Neurosci Res; 2017 Apr; 95(4):992-999. PubMed ID: 27546887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
    Qin X; Wang Y; Paudel HK
    Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
    Tomita T
    Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.